Omnadren – Jelfa | box 5amp x 1ml | 250 mg/ml by Pharmacy Steroids and Medications is a pharmaceutical-grade injectable formulation engineered to deliver sustained anabolic and androgenic activity. Composed of four distinct testosterone esters—Testosterone Propionate, Testosterone Phenylpropionate, Testosterone Isocaproate, and Testosterone Decanoate—it provides an immediate surge in circulating testosterone followed by extended release over a multi-week period. This kinetic profile mirrors the physiological dynamics found in clinical Sustanon therapies, ensuring balanced androgen levels with minimal peak-to-trough fluctuations.
Upon intramuscular delivery, esterases systematically cleave the carbon chains, releasing free, bioactive testosterone into systemic circulation. Testosterone binds directly to intracellular androgen receptors (AR), stimulating genomic transcription to promote nitrogen retention, muscle protein synthesis, and enhanced satellite cell proliferation. Furthermore, Omnadren elevates erythropoietin (EPO) production in the kidneys, leading to increased red blood cell count, improved oxygen-carrying capacity, and accelerated recovery times during intense resistance training.
Due to the short-acting propionate and phenylpropionate esters, bi-weekly injections are typically recommended to maintain stable blood plasma concentrations and reduce androgenic spikes. Common therapeutic replacement protocols range between 250 mg administered every two to three weeks, whereas performance enhancement cycles generally employ 250 mg to 750 mg per week depending on individual experience, body mass, and tolerance.
Omnadren operates as an effective foundation across mass-building and recomping regimens. Common synergistic pairings include:
Because testosterone aromatizes into 17-beta-estradiol, users must monitor for estrogen-related side effects such as gynecomastia, fluid retention, and elevated blood pressure. Ancillary use of aromatase inhibitors (e.g., Anastrozole or Exemestane) may be integrated as needed. Complete recovery of the hypothalamic-pituitary-gonadal (HPG) axis necessitates a comprehensive PCT protocol initiated 18–21 days post-last injection, incorporating SERMs such as Tamoxifen (Nolvadex) and Clomiphene (Clomid).
Although the longer decanoate ester remains active for weeks, optimal hormonal stability is achieved by dividing the weekly dosage into two equal deep intramuscular injections (e.g., Monday and Thursday).
Both formulations utilize a four-ester testosterone matrix designed for staggered release. Omnadren produced by Pharmacy Steroids and Medications features modern ester configurations matching Sustanon 250 standards, ensuring consistent bioavailability.
Due to the extended half-life of Testosterone Decanoate, standard post-cycle therapy should begin approximately 18 to 21 days following your final injection to allow systemic testosterone concentrations to clear sufficiently.
